Compare CNTN & ARQQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CNTN | ARQQ |
|---|---|---|
| Founded | 2017 | 2017 |
| Country | United States | United Kingdom |
| Employees | 12 | 91 |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 185.3M | 211.3M |
| IPO Year | 2022 | N/A |
| Metric | CNTN | ARQQ |
|---|---|---|
| Price | $2.84 | $23.29 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $60.00 |
| AVG Volume (30 Days) | 1.3M | ★ 1.4M |
| Earning Date | 05-13-2026 | 05-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $381.13 |
| Revenue Next Year | N/A | $212.00 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.14 | $11.52 |
| 52 Week High | $5.27 | $62.00 |
| Indicator | CNTN | ARQQ |
|---|---|---|
| Relative Strength Index (RSI) | 46.09 | 53.96 |
| Support Level | $2.14 | $21.80 |
| Resistance Level | $3.80 | $30.28 |
| Average True Range (ATR) | 0.31 | 4.36 |
| MACD | -0.01 | 0.40 |
| Stochastic Oscillator | 19.83 | 56.83 |
Canton Strategic Holdings Inc is engaged in activities related to Canton Network, including the use of Canton Coin, to support blockchain-based infrastructure and the digitization of financial market processes. The company also operates a validator node on the Canton Network to facilitate transaction validation and network operations. It also operates a clinical-stage biotech research and development arm. Its flagship clinical asset, GV104, is being developed for a specific indication for respiratory and/or nervous system depression in military personnel and chemical incident responders. The expanded pipeline includes other indications for GV104 and GV023, an approach to autoimmune diseases as well as an early-stage multispecific biologic platform.
Arqit Quantum Inc is a cybersecurity company that has pioneered a symmetric key agreement technology that makes the communications links of any networked device or data at rest secure against current and future forms of cyber attack - even an attack from a quantum computer. The company delivers its symmetric key agreement technology via its product SKA-Platform. The firm operates in one segment, that is, the provision of cybersecurity services. The company operates and generates its revenue from UK.